Skip to main content
OpenTrials

Clinical trial condition

Immune Thrombocytopenia (ITP)

Explore clinical trials studying Immune Thrombocytopenia (ITP). Study availability and eligibility vary by location and protocol.

30 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Immune Thrombocytopenia (ITP) trial results

Recruiting

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

NCT06371417

Conditions
Antiphospholipid Syndrome, Antiphospholipid Syndrome (APS), Autoimmune Diseases, +50 more
Locations
  • University of California-Irvine Orange, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Northwell Health, LLC PRIME Lake Success, New York, United States
  • Hospital for Special Surgery New York, United States
View all 77 locations
View Trial Details
Recruiting

A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

NCT07194850

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +22 more
Locations
  • Centre Hospitalier Universitaire de Bordeaux Groupe Hospitalier Pellegrin Hopital des Enfants Bordeaux, France
  • Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum (CVK) Berlin, Germany
  • Gaslini Children's Hospital Genoa, Italy
  • Fondazione IRCCS San Gerardo dei Tintori Monza, Italy
View all 20 locations
View Trial Details
Recruiting

A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia

NCT06721013

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Stanford University Stanford, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • University of Miami Hospital and Clinics Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 45 locations
View Trial Details
Recruiting

A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)

NCT07043946

Conditions
Anti-CD19, Autoimmune Diseases, Biologics, +20 more
Locations
  • Climb Bio Investigative Site #359202 Plovdiv, Bulgaria
  • Climb Bio Investigative Site #359203 Plovdiv, Bulgaria
  • Climb Bio Investigative Site #359201 Sofia, Bulgaria
  • Climb Bio Investigative Site #300204 Athens, Attica, Greece
View all 20 locations
View Trial Details
Recruiting

V-IMMUNE® for Immune Thrombocytopenia

NCT06962631

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • IMIP Instituto de Medicina Integral Professor Fernando Figueira Recife, Pernambuco, Brazil
  • Santa Casa de Misericórida de São Paulo São Paulo, Brazil
View Trial Details
Recruiting

The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)

NCT07065968

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Peking University Insititute of Hematology, Peking University People's Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
View Trial Details

Related conditions